Literature DB >> 24114760

Incidence and management of rhinosinusitis after complex orbitofacial reconstruction.

William J Parkes1, Gurston G Nyquist, Christopher Rizzi, Sarah Zhang, James J Evans, Ryan N Heffelfinger, Marc R Rosen, Joseph M Curry.   

Abstract

OBJECTIVES/HYPOTHESIS: To examine the sinus-related sequelae of free flap reconstruction for complex orbitofacial defects. STUDY
DESIGN: Retrospective chart review.
METHODS: Demographic, clinical, and radiographic data on a series of 55 patients who had undergone free tissue transfer for orbitofacial reconstruction was retrospectively reviewed. Follow-up of ≥ 3 months was available for 49 patients. Outcome measures studied included clinical or radiographic evidence of sinusitis and the need for sinus surgery.
RESULTS: The most commonly involved sinuses were the ethmoid (n = 40) and maxillary (n = 38) sinuses, and the anterolateral thigh was the most common flap used (n = 41). Clinical and/or radiographic sinusitis was evident in 21 patients (43%), and 10 patients (20%) required sinus surgery at some point during follow-up. Involvement of multiple sinuses in the initial orbitofacial surgery was associated with a significantly increased need for subsequent sinus surgery (P = 0.009). Adjuvant radiotherapy and adjuvant chemoradiotherapy were associated with a significantly increased risk for the development of rhinosinusitis (P = 0.045 and 0.016, respectively).
CONCLUSION: Rhinosinusitis and the need for operative management of sinus obstruction are common in patients having undergone complex orbitofacial reconstruction. Careful management of the paranasal sinuses is an important component of the multidisciplinary treatment of such patients.
© 2013 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Rhinosinusitis; free tissue transfer; orbitofacial; skullbase

Mesh:

Year:  2013        PMID: 24114760     DOI: 10.1002/lary.24423

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  1 in total

Review 1.  [Management and complications of tumor resections of the midface].

Authors:  Achim G Beule
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.